RankingsPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. Provision for income taxes

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

Market cap
$27.8B
P/E ratio
SummaryFinancials
Period EndProvision for income taxes (Million USD)YoY (%)
Dec 31, 2024676-9757.14%
Dec 31, 2023-7-98.90%
Dec 31, 2022-638-402.37%
Dec 31, 2021211-225.60%
Dec 31, 2020-168-39.57%
Dec 31, 2019-278+42.56%
Dec 31, 2018-195-89.91%
Dec 31, 2017-1,933-471.02%
Dec 31, 2016521-17.82%
Dec 31, 2015634+7.28%
Dec 31, 2014591-1474.42%
Dec 31, 2013-43-68.61%
Dec 31, 2012-137-207.87%
Dec 31, 2011127-55.12%
Dec 31, 2010283

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)